Pycnogenol® 190 Times More Potently than Prescription Diabetes Medications
Filed in archive Drugs, Vaccines and Therapeutics , Food and Agriculture on February 13, 2007
. Previously, pycnogenol has been demonstrated to reduce diabetic leg ulcers as well as reduce symptoms of attention deficit hyeractivity disorder (ADHD).
A study to be published in Diabetes Research and Clinical Practice also reveals that Pycnogenol delays the uptake of glucose from a meal 190 times more than synthetic prescription alpha-glucosidase inhibitors such as Precose®, and is thus more potent in preventing the typical high glucose peak in the blood stream after a meal.
"The high concentration of procyanidins (flavonoids) found in Pycnogenol® is responsible for demonstrating these excellent results," said Högger. According to Högger, the large procyanidin molecules were found to be particularly active for inhibiting the activity of alpha-glucosidase, thus demonstrating such notable results. "The carbohydrates enter the blood stream steadily over prolonged periods of time, which makes meals last longer and prolong satiety."
Pycnogenol® is a natural plant extract originating from the bark of the maritime pine that grows along the coast of southwest France.
Tags: pycnogenol diabetes alternative+medicine dietary+supplement biotech times+more prescription+diabetes
Vote for Pycnogenol® 190 Times More Potently than Prescription Diabetes Medications:
|
Rating: 6.75 out of 4 vote(s) cast.
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
